PCRXPacira BioSciences, Inc.

NASDAQ · Healthcare · Small Cap · Mkt cap $170M · Vol 19.00M

$16.96

▲ +3.29% today

Fetching live price…

God's Eye forensics

Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.

Piotroski F-Score

5/5

5

5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).

Altman Z-Score

Insufficient data

—

Needs total assets, operating profit and debt — not published for this listing yet.

Beneish (earnings quality)

Insufficient data

—

The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.

Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.

Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now

P/E Ratio (TTM)

Modeled

28.1x

Fairly priced

Contextual insight — DeepScreen Pro

PEG Ratio

Modeled

0.94

Undervalued vs. growth

Contextual insight — DeepScreen Pro

P/S Ratio

Modeled

3.88x

Moderate

Contextual insight — DeepScreen Pro

P/B Ratio

Modeled

8.43x

Typical for the sector

Contextual insight — DeepScreen Pro

EV/Revenue

Modeled

4.28x

Typical for the sector

Contextual insight — DeepScreen Pro

EV/EBITDA

Modeled

17.1x

Fair

Contextual insight — DeepScreen Pro

ROE

Modeled

30.0%

Excellent shareholder returns

Contextual insight — DeepScreen Pro

ROA

Modeled

17.0%

Strong for asset-light

Contextual insight — DeepScreen Pro

ROCE

Modeled

21.7%

High-quality compounder

Contextual insight — DeepScreen Pro

Debt / Equity

Modeled

0.41x

Conservative balance sheet

Contextual insight — DeepScreen Pro

LT Debt / Equity

Modeled

0.23x

Very low structural debt

Contextual insight — DeepScreen Pro

Payout Ratio

Modeled

21%

Growth company — reinvesting most profit

Contextual insight — DeepScreen Pro

Operating Leverage

Modeled

2.26x

Good upside gearing

Contextual insight — DeepScreen Pro

Company financials

EPS (TTM): $0.60
Revenue (TTM): $40M
Net margin: 13.8%
EBITDA margin: 25%
Earnings growth: 29.9%
Dividend yield: 0.75%
Payout ratio: 21%
Debt / equity: 0.41x

Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.

PCRX live news

LIVE

Loading live headlines…